GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Selling, General, & Admin. Expense

Whanin Pharm Co (XKRX:016580) Selling, General, & Admin. Expense : ₩36,625 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Whanin Pharm Co's selling, general, & admin. expense for the three months ended in Mar. 2024 was ₩8,933 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩36,625 Mil.


Whanin Pharm Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Whanin Pharm Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Selling, General, & Admin. Expense Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23,565.76 25,572.60 29,078.95 35,291.31 36,418.17

Whanin Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,726.86 8,989.02 9,435.99 9,266.30 8,933.24

Competitive Comparison of Whanin Pharm Co's Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Selling, General, & Admin. Expense falls into.



Whanin Pharm Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩36,625 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Whanin Pharm Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co (XKRX:016580) Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines